IulianaShapiraMD
Oncology • Hackensack, NJCancer Genetics/Cancer Risk Assessment, Gastrointestinal Cancer, Hematologic Oncology
Associate Professor Medicine & Cell Biology State University of New York Brooklyn
Dr. Shapira is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Regional Cancer Care Associates LLC
25 Main Street suite 601
Hackensack, NJ 07601Phone+1 201-243-3227Fax+1 201-620-3118- Is this information wrong?
Summary
- I am a board certified oncologist, hematologist and internal medicine doctor. I have over a decade experience in Oncology Leadership both in Integrated private and academic oncology settings.
Education & Training
SUNY Downstate Health Sciences UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005
Rutgers Health/Cooperman Barnabas Medical CenterResidency, Internal Medicine, 1995 - 1998
Carol Davila University of Medicine and PharmacyClass of 1990
Certifications & Licensure
NY State Medical License 2002 - 2026
CT State Medical License 2019 - 2025
NJ State Medical License 2019 - 2025
MD State Medical License 2019 - 2025
WY State Medical License 2019 - 2024
PA State Medical License 2019 - 2024
MS State Medical License 2001 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Top Oncologist Castle Connolly, 2020
Clinical Trials
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Publications & Presentations
PubMed
- 34 citationsAdjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.Tolaney, S., Tarantino, P., Graham, N., Tayob, N., Parè, L., Villacampa, G., Dang, C., Yardley, D., Moy, B., Marcom, P., Albain, K., Rugo, H., Ellis, M., Shapira, I., ...> ;The Lancet. Oncology. 2023 Mar 1
- 5 citationsPrivacy Concerns About Personal Health Information and Fear of Unintended Use of Biospecimens Impact Donations by African American PatientsArthi Reddy, Abhimanyu Amarnani, Michael Chen, Sophia Dynes, Bryan Flores, Ariella Moshchinsky, Yeon Joo Lee, Vadim Kurbatov, Iuliana Shapira, Shivakumar Vignesh, Laur...> ;Journal of Cancer Education. 2020 Jun 1
- 164 citationsSeven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast CancerSara M. Tolaney, Hao Guo, Sonia Pernas, William T. Barry, Deborah A. Dillon, Lauren L. Ritterhouse, Bryan P. Schneider, Fei Shen, Kit Fuhrman, Michele Baltay, Chau T. ...> ;Journal of Clinical Oncology. 2019 Apr 2
- Join now to see all
Press Mentions
Dr Iuliana Shapira Weighs in on How Data Analytics Can Improve Revenue CycleAugust 8th, 2019
Hopeful News for Cancer Patients from Iuliana Shapira, MD, RCCA's Chief Medical OfficerJuly 25th, 2019
® Announces the Institute for Value-Based Medicine® VB-Onc™ Meeting in New JerseyJune 6th, 2019- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
SUNY Downstate Health Sciences UniversityBrooklyn, New York
NYC Health + Hospitals / Kings CountyBrooklyn, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
